Share on LinkedInShare on LinkedIn

ARTICLE · 01 MARCH 2022

Proposed Canadian Drug Pricing Rules Delayed By Feds And Battered By Courts

In late December 2021, a postponement of the amended Patented Medicines Regulations was announced until July 1, 2022. This was the fourth time that the federal government delayed the implementation date of the rules.

CanadaIntellectual Property

In late December 2021, a postponement of the amended Patented Medicines Regulations was announced until July 1, 2022. This was the fourth time that the federal government delayed the implementation date of the rules. This marks two years of delays, with little public transparency about implementation or further amendment, causing consternation among drug industry observers that important drug pricing issues were being left in indefinite limbo. 

In the meantime, the Federal Court of Canada and Quebec courts have both held that portions of the new rules will not make it past the limbo stick, because they go beyond permitted federal jurisdiction. This article will focus on the very recent Quebec Court of Appeal decision, and explain it in relation to the draft rules and the Federal Court case. 

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from